In partnership with:
This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
GRL-079, a novel P2-Tp-THF-C5-alkylamine- and P2’ -Abt-containing HIV-1 protease inhibitor, is extremely potent against multi-drug-resistant HIV-1 variants including HIVDRVRp51 and has a high genetic barrier against the emergence of resistant variants
Nicole S. Delino, Manabu Aoki, Hironori Hayashi, Shin-ichiro Hattori, Simon B. Chang, Yuki Takamatsu, Cuthbert D. Martyr, Debananda Das, Arun K. Ghosh, Hiroaki Mitsuya- Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals
- DOI: 10.1128/aac.02060-17